IRIS
ROMANO, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.410
EU - Europa 3.119
AS - Asia 1.897
SA - Sud America 105
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 8.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.360
SG - Singapore 683
IT - Italia 662
CN - Cina 532
IE - Irlanda 471
UA - Ucraina 451
SE - Svezia 377
TR - Turchia 349
GB - Regno Unito 348
FR - Francia 278
IN - India 220
DE - Germania 204
FI - Finlandia 116
RU - Federazione Russa 83
BR - Brasile 78
AT - Austria 38
CA - Canada 34
HK - Hong Kong 32
VN - Vietnam 22
NL - Olanda 21
PE - Perù 15
BE - Belgio 14
CZ - Repubblica Ceca 13
IR - Iran 12
ES - Italia 11
EU - Europa 11
PL - Polonia 11
EG - Egitto 10
AU - Australia 9
BZ - Belize 9
IL - Israele 7
JP - Giappone 7
KR - Corea 7
AR - Argentina 6
TW - Taiwan 5
CL - Cile 4
RO - Romania 4
MA - Marocco 3
PA - Panama 3
PK - Pakistan 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EE - Estonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 8.571
Salva come PNG Salva come JPEG
Città #
Chandler 666
Jacksonville 516
Dublin 465
Singapore 444
Southend 268
Princeton 207
Izmir 201
Nanjing 132
Ashburn 113
Dearborn 112
Santa Clara 109
Boardman 107
The Dalles 105
Chieti 101
New York 98
Altamura 90
Beijing 88
Wilmington 88
Cambridge 80
Ann Arbor 73
Nanchang 63
Pescara 53
Rome 41
Los Angeles 36
Helsinki 35
Montesilvano 34
Vienna 33
San Mateo 29
Hebei 24
Washington 24
Woodbridge 24
Tianjin 23
Dong Ket 22
Shenyang 22
Düsseldorf 21
Jiaxing 21
Kunming 21
Falls Church 20
Hong Kong 19
Augusta 18
Houston 18
Nuremberg 18
Toronto 17
Brussels 14
Cornaredo 14
Grevenbroich 14
Montreal 13
Munich 13
Central 12
Changsha 12
Milan 12
Ica 10
Orange 10
San Buono 10
Seattle 10
Brno 9
Cairo 9
Ascoli Piceno 8
Hangzhou 8
Jinan 8
Frankfurt am Main 7
Lanzhou 7
Leawood 7
Meylan 7
Norwalk 7
Piotrkow Trybunalski 7
Tokyo 7
Ancona 6
Changchun 6
Chengdu 6
London 6
Ningbo 6
Tappahannock 6
Fuzhou 5
Hefei 5
Lanciano 5
Lima 5
Madrid 5
Melbourne 5
Redwood City 5
Saint-prix 5
Shanghai 5
Vasto 5
Amsterdam 4
Ardabil 4
Auburn Hills 4
Bari 4
Chicago 4
Falkenstein 4
Guangzhou 4
Haikou 4
Jundiaí 4
Lappeenranta 4
Napoli 4
Rochester 4
Saint-Saens 4
Alessandria 3
Assergi 3
Belgrade 3
Casalbordino 3
Totale 5.084
Salva come PNG Salva come JPEG
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 264
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 155
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 144
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 141
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 137
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 136
Establishment and long-term culture of human cystic fibrosis endothelial cells 133
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 132
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 129
Pentraxin 3 and platelet activation in obese patients after gastric banding 129
Mechanisms of endothelial cell dysfunction in cystic fibrosis 128
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 121
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 114
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 106
Lipoxins, resolvins, and the resolution of inflammation 104
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 103
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 101
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 100
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 99
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 98
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 97
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 97
Increased soluble CD40L levels in cystic fibrosis 95
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 95
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 94
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 94
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 94
Lipoxin receptors 92
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 91
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 91
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 91
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 90
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 89
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 89
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 89
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 88
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 88
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 88
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 87
Epigenetic regulation of the formyl peptide receptor 2 gene 86
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 86
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 85
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 85
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 84
Transcellular regulation of eicosanoids biosyntesis 84
Leptin increase is associated with markers of the hemostatic system in obese healthy women 82
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 81
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 80
Increased levels of soluble P-selectin in hypercholesterolemic patients 80
Homocysteine modulates the CD40/CD40L system 80
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 79
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 79
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 78
Induction of functional Lipoxin A4 receptors in HL-60 cells 77
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 77
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 77
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 76
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 76
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 75
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 75
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 74
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 74
Reduced platelet mitogenic activity in myeloproliferative disorders 74
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 73
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 73
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 73
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 72
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 72
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 72
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 72
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 71
Lipoxin synthase activity of human platelet 12-Lipoxygenase 70
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 70
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 70
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 70
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 70
Lipoxin and aspirin-triggered lipoxins 70
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 67
Ligand bias and its association with pro-resolving actions of melanocortin drugs 67
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 66
Inflammation resolution: does the bone marrow have a say? 66
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 66
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 65
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 65
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 65
Lipoxin generation by permeabilized human platelets 64
Human alveolar macrophages generate 15-HETE and can produce lipoxins 64
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 63
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 63
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 62
Endothelial perturbation in cystic fibrosis. 62
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 62
Lipoxin analogs and lipoxin formation in vivo 62
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 61
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 58
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 58
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 55
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 55
Lower platelet count in centenarians correlates with dispersion of the Q-T interval 52
The Resolution Approach to Cystic Fibrosis Inflammation 52
Totale 8.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 0 0 0 0 0 0 121 7
2020/2021807 102 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20251.709 130 381 319 83 81 97 78 118 246 92 84 0
Totale 8.978